Mirae Asset Global Investments’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,713
Closed -$319K 1579
2024
Q1
$319K Sell
25,713
-8,567
-25% -$50.9K ﹤0.01% 2087
2023
Q4
$269K Buy
34,280
+270
+0.8% +$1.87K ﹤0.01% 2240
2023
Q3
$249K Buy
34,010
+3,442
+11% +$28.6K ﹤0.01% 2214
2023
Q2
$319K Buy
30,568
+4,855
+19% +$46.7K ﹤0.01% 2161
2023
Q1
$266K Buy
25,713
+3,192
+14% +$40.9K ﹤0.01% 2218
2022
Q4
$310K Hold
22,521
﹤0.01% 2142
2022
Q3
$461K Buy
22,521
+3,161
+16% +$69.4K ﹤0.01% 1912
2022
Q2
$375K Buy
+19,360
New +$396K ﹤0.01% 1884

Other funds holding ANGO

Mirae Asset Global Investments's ANGO Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 25,713 shares — an estimated $319K sold.

Mirae Asset Global Investments first reported a position in ANGO in Q2 2022 and held it in 8 quarters. The position peaked at $461K in Q3 2022. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 25,713 AngioDynamics shares in Q2 2024, an estimated $319K.
  • Mirae Asset Global Investments first reported a position in AngioDynamics in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's AngioDynamics position peaked at $461K in Q3 2022.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.